Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Iodine I 131 Tositumomab in Relapsed Follicular NHL
NCT00268983Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2004
- Primary completion
- Sep 2009
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of iodine i 131 tositumomab in follicular lymphoma (FL), sponsored by GSK. Started Oct 2004; status: completed.
02
Drugs
iodine i 131 tositumomab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00268983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268983.